Literature DB >> 12228231

Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding.

Xiaohui Zhang1, Lixia Gan, Haiyun Pan, Shaodong Guo, Xiaowei He, Steven T Olson, Andrew Mesecar, Stephen Adam, Terry G Unterman.   

Abstract

FKHR is a member of the FOXO subfamily of Forkhead transcription factors, which are important targets for insulin and growth factor signaling. FKHR contains three predicted protein kinase B phosphorylation sites (Thr-24, Ser-256, and Ser-319) that are conserved in other FOXO proteins. We have reported that phosphorylation of Ser-256 is critical for the ability of insulin and insulin-like growth factors to suppress transactivation by FKHR (Guo, S., Rena, G., Cichy, S., He, X., Cohen, P., and Unterman, T. (1999) J. Biol. Chem. 274, 17184-17192) and for its exclusion from the nucleus (Rena, G., Prescott, A. R., Guo, S., Cohen, P., and Unterman, T. G. (2001) Biochem. J. 354, 605-612). Ser-256 is located in a basic region of the FKHR DNA binding domain where phosphorylation may have direct effects on DNA binding and/or nuclear targeting. Phosphorylation of Ser-256 may also be required for the phosphorylation of Thr-24 and Ser-319. Here, we provide the first direct evidence that basic residues in the FKHR DNA binding domain are critical for DNA binding and that Ser-256 phosphorylation alters binding activity. Ser-256 phosphorylation also is critical for regulating nuclear/cytoplasmic trafficking; however, this effect requires Thr-24/Ser-319 phosphorylation. Transient transfection studies with reporter gene constructs in 293 cells reveal that the phosphorylation of Ser-256 can inhibit the function of FKHR independent of Thr-24/Ser-319 phosphorylation. Studies with GFP(1) fusion proteins indicate that Ser-256 phosphorylation is critical for nuclear exclusion of FKHR. However, this effect is disrupted when Thr-24 and Ser-319 are replaced by alanine, indicating that nuclear exclusion of FKHR also requires Thr-24/Ser-319 phosphorylation. Gel shift and fluorescence anisotropy studies reveal that basic residues at the C-terminal end of the FKHR DBD are important for DNA binding, and the introduction of a negative charge at the site of Ser-256 limits binding activity. Binding is rapid and reversible, providing an opportunity for the phosphorylation of Ser-256 and subsequent phosphorylation of Thr-24 and Ser-319 and nuclear exclusion of FKHR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228231     DOI: 10.1074/jbc.M208063200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  118 in total

1.  Chitosan Degradation Products Promote Nerve Regeneration by Stimulating Schwann Cell Proliferation via miR-27a/FOXO1 Axis.

Authors:  Yongjun Wang; Yahong Zhao; Cheng Sun; Wen Hu; Jing Zhao; Guicai Li; Luzhong Zhang; Mei Liu; Yan Liu; Fei Ding; Yumin Yang; Xiaosong Gu
Journal:  Mol Neurobiol       Date:  2014-11-18       Impact factor: 5.590

Review 2.  The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.

Authors:  Lars P Van Der Heide; Marco F M Hoekman; Marten P Smidt
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

3.  FoxO1 links hepatic insulin action to endoplasmic reticulum stress.

Authors:  Adama Kamagate; Dae Hyun Kim; Ting Zhang; Sandra Slusher; Roberto Gramignoli; Stephen C Strom; Suzanne Bertera; Steven Ringquist; H Henry Dong
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

4.  Induction of cyclin D2 in rat granulosa cells requires FSH-dependent relief from FOXO1 repression coupled with positive signals from Smad.

Authors:  Youngkyu Park; Evelyn T Maizels; Zachary J Feiger; Hena Alam; Carl A Peters; Teresa K Woodruff; Terry G Unterman; Eun Jig Lee; J Larry Jameson; Mary Hunzicker-Dunn
Journal:  J Biol Chem       Date:  2004-12-21       Impact factor: 5.157

5.  Regulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7.

Authors:  Jia Yu; Bo Qin; Fengying Wu; Sisi Qin; Somaira Nowsheen; Shan Shan; Jacqueline Zayas; Huadong Pei; Zhenkun Lou; Liewei Wang
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

6.  Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy.

Authors:  Christopher A Klebanoff; Joseph G Crompton; Anthony J Leonardi; Tori N Yamamoto; Smita S Chandran; Robert L Eil; Madhusudhanan Sukumar; Suman K Vodnala; Jinhui Hu; Yun Ji; David Clever; Mary A Black; Devikala Gurusamy; Michael J Kruhlak; Ping Jin; David F Stroncek; Luca Gattinoni; Steven A Feldman; Nicholas P Restifo
Journal:  JCI Insight       Date:  2017-12-07

Review 7.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

8.  Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation.

Authors:  Hitomi Matsuzaki; Hiroaki Daitoku; Mitsutoki Hatta; Hisanori Aoyama; Kenji Yoshimochi; Akiyoshi Fukamizu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-02       Impact factor: 11.205

9.  Regulation of insulin-response element binding protein-1 in obesity and diabetes: potential role in impaired insulin-induced gene transcription.

Authors:  Jaspreet Chahal; Ching-Chu Chen; Madhavi J Rane; Joseph P Moore; Michelle T Barati; Ying Song; Betty C Villafuerte
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

10.  Akt- and Foxo1-interacting WD-repeat-FYVE protein promotes adipogenesis.

Authors:  Thorsten Fritzius; Karin Moelling
Journal:  EMBO J       Date:  2008-04-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.